FDA tells drug maker to pull powerful opioid off the market

(Ars Technica, June 9) The Food and Drug Administration recently asked Endo Pharmaceuticals stop selling its opioid drug, Opana ER (oxymorphone hydrochloride), because of the  “public health consequences of abuse.” Read more.